PCCTC Collaborates with Florence Healthcare to Enhance Regulatory Document Management Capabilities
ATLANTA, GA and NEW YORK, June 10, 2016 – Florence Healthcare, developer of the innovative trial site-focused electronic trial site and master file (eTMF) platform, eBinder Suite™, and the Prostate Cancer Clinical Trials Consortium (PCCTC), the nation’s leading multicenter clinical research organization specializing in cutting-edge prostate cancer research, today announced their new collaboration to expand and enhance the Consortium’s trial management capabilities.
“The complexities of ensuring the accuracy and compliance of study documents cannot be underestimated,” commented PCCTC CEO Jake Vinson. “Deploying Florence’s eTMF within the PCCTC has the potential to shorten the time it takes to bring safe and effective products our investigators develop to market.”
Internationally recognized leaders in the field, PCCTC members work together on a single mission: to design, implement and complete hypothesis-driven early phase trials in prostate cancer, translating scientific discoveries to improved standards of care. To do so the PCCTC coordinates the intricate details of regulatory document management throughout a project’s lifecycle, serving as a single point of contact for industry partners and investigators.
Florence partners with leading institutions to make research run faster. Specifically, the eBinder Suite helps investigator teams take on more studies and reduce compliance risks, so that new therapies can reach those in need, sooner.
“Florence focuses on converting wasteful paper chores into one-click tasks—tasks that not only reduce site work but deliver insights to study sponsors”, described by Florence Clinical Director Mike Kassin, MD. “PCCTC has a track record of making research more efficient for both sites and sponsors overall, and we’re delighted to support them as they advance the battle against cancer.”
About the Prostate Cancer Clinical Trials Consortium (PCCTC)
In 2005, the Prostate Cancer Foundation and the Department of Defense (DOD) Prostate Cancer Research Program (PCRP) initiated the Prostate Cancer Clinical Trials Consortium (PCCTC) in response to gaps identified in prostate cancer clinical research by physician investigators and prostate cancer advocates. By establishing transparent project co-development between investigators, research sites and industry partners, the PCCTC has created a new paradigm for evaluating prostate cancer therapies. Uniform trial endpoints, the use of validated biomarkers, and the adaptation of the clinical states model of prostate cancer have further enabled accelerated drug development within the consortium. The PCCTC is now a major multi-institutional clinical research organization consisting of a nationwide network of physicians at over 20 academic institutions specializing in cutting-edge prostate cancer research. For more information, please visit www.pcctc.org.
About Florence eBinder Suite
Florence, founded by experts in document management (Microsoft SharePoint), enterprise security (Airwatch / VMWare), clinical trials (Emory + Medtronic) is focused on advancing clinical research through software. Hundreds of sponsors and sites around trust Florence eBinders to move past paper study roadblocks and enable new approaches to managing trials. Florence is based in Atlanta, Georgia.
To arrange an interview with the Florence team or for more information, please mail email@example.com